tert-butyl 3-phenoxyazetidine-1-carboxylate | 1600493-72-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: tert-butyl 3-phenoxyazetidine-1-carboxylate
• 英文别名: tert-Butyl 3-phenoxyazetidine-1-carboxylate
• CAS: 1600493-72-8
• 化学式: C₁₄H₁₉NO₃
• 分子量: 249.31
• InChiKey: CTNHCTDBYOYTEG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1-Boc-3-碘氮杂环丁烷 、 苯酚 在 potassium phosphate 、 copper(l) iodide 、 氧气 、 L-脯氨酸 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 反应 22.0h， 以60%的产率得到tert-butyl 3-phenoxyazetidine-1-carboxylate
  参考文献：
  名称：

  Synthesis of aryloxyazetidine derivatives by CuI/l-proline catalyzed coupling reaction of arylboronic acid with 1-Boc-3-iodoazetidine

  摘要：

  A novel CuI/L-proline catalyzed coupling reaction of 1-Boc-3-iodoazetidine with various arylboronic acids which produced aryloxyazetidine derivatives in moderate to good yields was investigated. (C) 2014 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tetlet.2014.02.098

文献信息

• [EN] COMPOUNDS AND METHODS OF TREATING CANCERS<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE CANCERS
  申请人：CULLGEN SHANGHAI INC

  公开号：WO2022073469A1

  公开（公告）日：2022-04-14

  This disclosure relates to GSPT1 degrader compounds (e.g. small molecule compounds), compositions comprising one or more of the compounds, and to methods of use the compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such compounds.

  本公开涉及GSPT1降解剂化合物（例如小分子化合物），包含一种或多种该化合物的组合物，以及使用该化合物治疗特定疾病的方法，适用于需要该治疗的个体。本公开还涉及识别这种化合物的方法。
• COMPOUNDS AND USES THEREOF
  申请人：Yumanity Therapeutics, Inc.

  公开号：US20210139471A1

  公开（公告）日：2021-05-13

  The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
• [EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS
  申请人：YUMANITY THERAPEUTICS INC

  公开号：WO2020154571A1

  公开（公告）日：2020-07-30

  The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.